SEC Form 4/A · accession 0001209191-19-003177
Nightstar Therapeutics plc · NITE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Gregory Scott Robinson
Officer — Chief Scientific Officer
Period of report
Jan 2, 2019
Accepted (ET)
Jan 9, 2019 · 9:08 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001711675
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1,F3 | Jan 2, 2019 | S | 14,764 | $11.15 | D | 104,017 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The ordinary shares, nominal value GBP 0.01 per share, of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents one ordinary share of the Issuer.
- F2This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person
- F3On January 4, 2019, a Form 4 was filed to report the January 2, 2019 sale of 14,764 ordinary shares pursuant a 10b5-1 plan previously adopted by the Reporting Person. The report provided by the Issuer's equity administrator contained errors relating to the Reporting Person's holdings which have been corrected herein. This Form 4/A amends and restates, in its entirety, the original Form 4.